Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pressure Biosciences (OP: PBIO ) 0.0255 UNCHANGED Streaming Delayed Price Updated: 2:36 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pressure Biosciences < Previous 1 2 3 4 5 6 7 8 9 10 Next > InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth July 21, 2022 Via Investor Brand Network Topics Cannabis Exposures Cannabis Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform July 21, 2022 PBI Partners with Leading Colorado Cannabis Company for Manufacture and Distribution of Novel Nano-CBD Topical Spray and Other Products, Anticipating $2 Million in 2023 Revenue Contribution From Pressure BioSciences Inc. Via AccessWire Topics Cannabis Exposures Cannabis Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform July 21, 2022 Via ACCESSWIRE InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Upcoming Emerging Growth Conference July 06, 2022 Via Investor Brand Network Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M July 06, 2022 Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A Session From Pressure BioSciences Inc. Via AccessWire InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present at 34th Emerging Growth Conference July 05, 2022 Via Investor Brand Network InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation in Upcoming Webinar Focused on Revolutionizing Development of Plant-Based Food Products June 30, 2022 Via Investor Brand Network Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products June 30, 2022 Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A Event From Pressure BioSciences Inc. Via AccessWire InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters ‘Pivotal’ Agreement for Nanoemulsified CBD Spray for Oral Use June 29, 2022 Via Investor Brand Network Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use June 29, 2022 Safer Medical of Montana, a Seasoned Distributor of Wellness Products with a Focus on Veterans, Partners with PBI as Exclusive Distributor for Highly Stable and Water-Soluble CBD Oral Aerosol Product From Pressure BioSciences Inc. Via AccessWire InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’ June 14, 2022 Via Investor Brand Network Global Plant Based Protein Market Expected To Reach $40 Billion by 2027 June 14, 2022 Palm Beach, FL – June 14, 2022 – FinancialNewsMedia.com News Commentary – The pandemic has considerably transformed consumer buying patterns, with a steady shift being witnessed toward health-improving... Via FinancialNewsMedia Pressure BioSciences’ Ultra Shear Technology™ Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market June 14, 2022 Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI’s UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages South... Via FinancialNewsMedia Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market June 14, 2022 Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages From Pressure BioSciences Inc. Via AccessWire InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program on Stock Day Podcast June 01, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast June 01, 2022 Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"... Via Newsfile Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured in New ‘TechTalks’ Video May 24, 2022 Via Investor Brand Network Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher May 24, 2022 SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business... From Pressure BioSciences Inc. Via AccessWire Pressure BioSciences, Inc. Reports Q1 2022 Financial Results May 19, 2022 Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and... From Pressure BioSciences Inc. Via AccessWire Topics Economy Exposures COVID-19 Supply Chain Pressure BioSciences Signs Multi-Year Manufacturing Agreement; To Be First Product Commercially Sold Into Consumer Market Containing UST-Produced Nanoemulsion May 05, 2022 Image sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update May 20, 2022 Via Investor Brand Network InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreement May 04, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program May 04, 2022 Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain Reduction Via Benzinga Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program May 04, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Pressure BioSciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate at Upcoming Planet MicroCap Showcase May 03, 2022 Via Investor Brand Network Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022 May 03, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Pressure BioSciences Inc. Via AccessWire SRAX (NASDAQ: SRAX) Releases Replays From 2022 Cannabis And Psychedelic Conference April 27, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Early Access Program for Use of Its Revolutionary UST(TM) Platform April 27, 2022 Via Investor Brand Network Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing April 27, 2022 Strong Market Demand Fuels Company's Decision to Access Early Revenue Generating Opportunities for UST Processing of High Quality Nanoemulsions of Oil-Based Active Ingredients for Multiple Markets... From Pressure BioSciences Inc. Via AccessWire InvestorNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Availability of Replays from the 2022 Sequire Cannabis and Psychedelic Conference April 26, 2022 Via Investor Brand Network Topics Cannabis Exposures Cannabis < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.